Back to Search
HERMAN GOMEZ, MD
MD
Internal Medicine Physician
NPI: 1639153414IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
151795(MA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1994
Research & Publications (20)
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.
PMID 18458039·J Clin Oncol·2008
3-trial
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression.
PMID 16467096·Clin Cancer Res·2006
3-trial
A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: a preliminary report.
PMID 11510035·Semin Oncol·2001
3-trial
Analysis of dermatologic events in patients with cancer treated with lapatinib.
PMID 18600445·Breast Cancer Res Treat·2009
6-review
Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer.
PMID 19483734·Nat Rev Clin Oncol·2009
8-other
Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.
PMID 19289659·Arch Surg·2009
8-other
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer.
PMID 18256882·Ann Surg Oncol·2008
8-other
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.
PMID 18955454·J Clin Oncol·2008
3-trial
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
PMID 18371219·Breast Cancer Res·2008
8-other
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib.
PMID 18323548·J Clin Oncol·2008
3-trial
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
PMID 17968020·J Clin Oncol·2007
3-trial
CYP2D6*4 polymorphism is associated with statin-induced muscle effects.
PMID 17700359·Pharmacogenet Genomics·2007
8-other
Diagnosis of loxoscelism in two Turkish patients confirmed with an enzyme-linked immunosorbent assay (ELISA) and non-invasive tissue sampling.
PMID 17498430·Dermatol Online J·2007
5-case
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
PMID 17329190·Lancet Oncol·2007
8-other
Diagnosis of loxoscelism in a child confirmed with an enzyme-linked immunosorbent assay and noninvasive tissue sampling.
PMID 17052500·J Am Acad Dermatol·2006
5-case
Pancreaticoduodenectomy after placement of endobiliary metal stents.
PMID 16269380·J Gastrointest Surg·2005
8-other
Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
PMID 15585381·J Gastrointest Surg·2004
8-other
Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance.
PMID 14742186·Antimicrob Agents Chemother·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 151 EVERETT AVE
CHELSEA, MA 02150 - Phone
- (617) 887-4600
Quick Facts
- NPI
- 1639153414
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile